Cardiology

Breast Cancer, Non-metastatic

Questions discussed in this category

How do you advise patients on cardiotoxicity when they are expected to receive a low mean heart dose and low cardiac substructure doses with their radiation plan?

Such as breast plans with < 200 cGy mean heart dose

1 Answer available

How would you treat an elderly patient with borderline cardiac dysfunction who has stage 3 HR+ HER2- breast cancer?

2 Answers available

Papers discussed in this category

Annals of Oncology, 2021 Sep 29

Adjuvant Abemaciclib Combined With Endocrine Therapy for High-Risk Early Breast Cancer: Updated Efficacy and Ki-67 Analysis From the monarchE Study.

Related Topics in Cardiology